The spectrum of mutations in TP53 in laryngeal cancer patients from a high-incidence population shows similarities to many of the known mutational hotspots

Cancer Genetics and Cytogenetics

Volumn 145, Issue 2, 2003, Pages 126-132

  Barnard, Desiré ^a   Lehmann, Karen ^a   Hoal, Eileen G ^a   Van Helden, Paul D ^a   Victor, Thomas C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; FOOD INTAKE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC SIMILARITY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MALE; MEAT; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC CELL GENETICS; TP53 GENE; TUMOR BIOPSY;

EID: 0042163167     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00064-5     Document Type: Article

References (32)

1. Hirvikoski P., Kumpulainen E., Virtaniemi J., Johansson R., Haapasalo H., Marin S., Halonen P., Helin H., Raitiola H., Pukander J., Kellokumpu-Lehtinen P., Kosma V.M. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol. 15:1997;3111-3120.
2. Cattaruzza M.S., Maisonneuve P., Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol. 32B:1996;293-305.
3. Dahse R., Fiedler W., von Eggeling F., Schimmel B., Koscielny S., Beleites E., Claussen U., Ernst G. P53 genotyping: an effective concept for molecular testing of head and neck cancer? Int J Mol Med. 4:1999;279-283.
4. Rowley H., Roland N.J., Helliwell T.R., Caslin A., Kinsella A.R., Jones A.S. p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol. 23:1998;57-62.
5. Hille J.J., Shear M., Sitas F. Age standardized incidence rates of oral cancer in South Africa, 1988-1991. J Dent Assoc S Afr. 12:1996;771-776.
6. Center for Laryngeal and Voice Disorders at Johns Hopkins. Laryngeal cancer [Internet]. Available at: http://www.med.jhu.edu/voice/cancer.html . Accessed July 3, 2001.
7. Gottschlich S., Maune S., Preugschat J., Hoffmann M., Werner J.A., Maass J.D., Gorogh T., Heidorn K., Rudert H. p53 analysis of laryngeal cancer in exon 4 to 9. Anticancer Res. 20:2000;2613-2616.
8. Soussi T., Dehouche K., Beroud C. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat. 15:2000;105-113.
9. Ayed A., Mulder F.A., Yi G.S., Lu Y., Kay L.E., Arrowsmith C.H. Latent and active p53 are identical in conformation. Nat Struct Biol. 8:2001;756-760.
10. Jeannon J.P., Soames J., Lunec J., Awwad S., Ashton V., Wilson J.A. Expression of cyclin dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Clin Otolaryngol. 25:2000;23-27.
11. Ribeiro U., Finkelstein S.D., Safatle-Ribeiro A., Landreneau R.J., Clarke M.R., Bakker A., Swalsky P.A., Gooding W.E., Posner M.C. p53 sequence analysis predicts treatment response and outcome of patients with esophageal cancer. Cancer. 83:1998;7-18.
12. Sun Y., Keshava C., Sharp D.S., Weston A., McCanlies C. DNA sequence variants of p53: cancer and aging. Am J Hum Genet. 65:1999;1779-1782.
13. Pietruszewska W., Kobos J., Gryczynski M. [Programmed cell death research in laryngeal cancer.] In Polish. Otolaryngol Pol. 54:(Suppl 31):2000;212-215.
14. Martin A.C., Facchiano A.M., Cuff A.L., Hernandez-Boussard T., Olivier M., Hainaut P., Thornton J.M. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein. Hum Mutat. 19:2002;149-164.
15. Marais J.S. The Cape coloured people, 1652 to 1932. Volume 1:1957;Witwatersrand University Press, Johannesburg. pp. 1-31.
16. Miller S.A., Dykes D.D., Polesky S.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
17. Toguchida J., Yamaguchi T., Ritchie B., Beauchamp R.L., Dayton S.H., Herrera G.E., Yamamuro T., Kotoura Y., Sasaki M.S., Little J.B. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52:1992;6194-6199.
18. Gamieldien W., Victor T.C., Mugwanya D., Stepien A., Gelderblom W.C., Marasas W.F., Geiger D.H., van Helden P.D. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high- incidence area in South Africa. Int J Cancer. 78:1998;544-549.
19. Hainaut, P. p53: an emergency brake for growth control at the interface between selection pressure and growth control [Internet]. Available at: http://www.cineca.it/networking/streaming/sestri/courses/cancgen/Hainaut.htm . Accessed August 14, 2001.
20. Sarkar F.H., Sakr W.A., Li Y.W., Jacobs J., Crissman J.D. Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx. Diagn Mol Pathol. 3:1996;201-205.
21. Bradford C.R., Zhu S., Poore J., Fisher S.G., Beals T.F., Thoraval D., Hanash S.M., Carey T.E., Wolf G.T. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs LC Cooperative Study Group. Arch Otolaryngol Head Neck Surg. 123:1997;605-609.
22. Zhang L.F., Hemminki K., Szyfter K., Szyfter W., Soderkvist P. p53 mutations in larynx cancer. Carcinogenesis. 12:1994;2949-2951.
23. Jego N., Thomas G., Hamelin R. Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene. 8:1993;209-213.
24. Skilling S.J., Sood A.K., Niemann T., Lager D.J., Buller R.E. An abundance of p53 null mutations in ovarian carcinoma. Oncogene. 13:1996;117-123.
25. Vos M., Adams C.H., Victor T.C., van Helden P.D. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet. 140:2003;23-30.
26. Montesano R., Hollstein M., Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 69:1996;225-235.
27. Steele R.J., Thompson A.M., Hall P.A., Lane D.P. The p53 tumour suppressor gene. Br J Surg. 85:1998;1460-1467.
28. Soussi T, Gallou C, Béroud C, editors. The p53 database [Internet]. Updated December 2001. Available at: http://p53.curie.fr/ . Accessed October 2002.
29. Maestro R., Dolcetti R., Gasarotto D., Doglioni C., Pelucchi S. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 7:1992;1159-1166.
30. Boyle J.O., Hakin J., Koch W., van der Riet P., Hruban R.H., Roa R.A., Correo R., Eby Y.J., Ruppert J.M., Sidransky D. The incidence of p53 mutations increase with progression of head and neck cancer. Cancer Res. 53:1993;4477-4480.
31. Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:1992;5997-6000.
32. Dominquez-Malagon H., Gayton-Graham S. Hepatocellular carcinoma: an update. Ultrastruct Pathol. 25:(6):2001;497-516.